EAM Global Investors’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,685	Closed	-$1.1M	–	160
2018 Q2	$1.1M	Sell	18,685 -5,135	-22%	-$302K	0.54%	115
2018 Q1	$1.09M	Buy	+23,820	New	+$1.09M	0.56%	93